Developer of a healthcare data and patient informatics platform designed to offer enhanced data discovery and distributi
Developer of a healthcare data and patient informatics platform designed to offer enhanced data discovery and distribution.
Enterprise Systems (Healthcare)📍 Philadelphia, PAFounded 2014
Current Valuation
$720M
as of 2021-Q2
PRIVATE
QL Price
$720M
0% vs last round
QuantLogix's current estimate for HealthVerity, published 2026-09-27 — in line with the last disclosed round of $720M (2021-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$720M
2021-Q2
weight 0.03
How this price has held up
No round has priced for HealthVerity since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, HealthVerity, 2026-09-27 (e36ecd6bd5c624b0).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is HealthVerity going public?
No. HealthVerity is private and has not filed to go public. There is no S-1 on file.
What is HealthVerity's valuation in 2026?
HealthVerity is valued at $720M as of 2021-Q2, set by its Series D ($100M, Jun 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has HealthVerity filed an S-1?
No public S-1 is on file for HealthVerity.
How much has HealthVerity raised?
HealthVerity has raised $142.26M in total, most recently a Series D of $100M in Jun 2021.
Is HealthVerity publicly traded — can you buy HealthVerity stock?
No. HealthVerity is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for HealthVerity on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2014
HQ
Philadelphia, PA
Employees
226
Total Raised
$142.26M
Last Round
Series D — $100M (Jun 2021)
IPO Status
private
Fundraising Status
Series D · $100M · 5y 3mo ago
privateTotal raised $142.26M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$100M
Jun 2021
—
$720M
Talent Signal
Hiring trend
▲ Hiring uptrend
+25% vs 2026-08
Open roles
20
via greenhouse
Product-build share
15%
engineering, research, product, design
Trajectory
scaling
go-to-market push — Only 15% of open roles build product — hiring is concentrated in sales/marketing/ops (7 of 20 open roles are other).
Executive bench growing while hiring expands: 1 senior hire (CTO); open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INAdam GreenfieldCTO · 2026-08-23
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Counted from HealthVerity's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareInformation TechnologyInformation Services
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q2. Refreshed quarterly.